However, these studies typically involved small sample sizes, lacked control groups, and could not definitively separate the effects of the medication itself from concurrent weight loss or improved glycaemic control
DESCRIPTION TABLE OF CONTENTS METHODOLOGY DOWNLOAD PDF Oral Proteins & Peptides Market by Molecule (Semaglutide, Linaclotide, Calcitonin), Drug Class (GLP-1, GPE, CGRP), Therapeutic Area (Nephrology, Gastroenterology, Genetic, CNS, Obesity, Diabetes), Formulation (Tablet, Capsule) - Global Forecast to 2030 USD 19.93 BN MARKET SIZE, 2030 OVERVIEW Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis The global oral proteins & peptides market is projected to reach USD 19.93 billion by 2030 from USD 9.31 billion in 2025, at a CAGR of 16.4% during the forecast period
Sourcing from verified suppliers with transparent purity testing eliminates the most common reconstitution and stability failures caused by truncated peptide sequences or synthesis byproducts
Valerie S
This product is not intended for athletic performance enhancement or bodybuilding purposes